Down Syndrome Global Clinical Trials Review, H2, 2015

1
Down Syndrome Global Clinical Trials Review, H2,
2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Down Syndrome Global Clinical Trials Review, H2,
  2015 provides an overview of Down Syndrome
  clinical trials scenario. This report provides
  top line data relating to the clinical trials on
  Down Syndrome. Report includes an overview of
  trial numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) .
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/down-s
  yndrome-global-clinical-trials-review-h2-2015-mark
  et

3


Table of Content
Table of ContentsTable of Contents 2List of
Tables 3List of Figures 4Report Guidance
5Clinical Trials by Region 6Clinical Trials and
Average Enrollment by Country 7Top Five
Countries Contributing to Clinical Trials in
Asia-Pacific 9Top Five Countries Contributing to
Clinical Trials in Europe 10Top Countries
Contributing to Clinical Trials in North America
11Top Countries Contributing to Clinical Trials
in Middle East and Africa 12Top Countries
Contributing to Clinical Trials in Central and
South America 13Clinical Trials by G7 Countries
Proportion of Down Syndrome to Genetic Disorders
Clinical Trials 14Clinical Trials by Phase in G7
Countries 15Clinical Trials in G7 Countries by
Trial Status 16Clinical Trials by E7 Countries
Proportion of Down Syndrome to Genetic Disorders
Clinical Trials 17Clinical Trials by Phase in E7
Countries 18Clinical Trials in E7 Countries by
Trial Status 19Clinical Trials by Phase 20
4


Table of Content
In Progress Trials by Phase 21Clinical Trials
by Trial Status 22Clinical Trials by End Point
Status 23Subjects Recruited Over a Period of
Time 24Clinical Trials by Sponsor Type
25Prominent Sponsors 26Top Companies
Participating in Down Syndrome Therapeutics
Clinical Trials 27Prominent Drugs 28Clinical
Trial Profile Snapshots 29Appendix
65Abbreviations 65Definitions 65Research
Methodology 66Secondary Research 66About
GlobalData 67Contact Us 67Disclaimer 67Source
68 Enquire At http//www.researchbeam.com/down-
syndrome-global-clinical-trials-review-h2-2015-mar
ket/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/down-syndrome-global-c
linical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com